Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Tejaswini Dhawale, M.D.

Concepts (66)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Hematologic Neoplasms5202419270.650 Why?
Lymphoma, Extranodal NK-T-Cell12017520.540 Why?
Terminal Care2202417740.480 Why?
Uncertainty120177610.390 Why?
Lymphoma, Non-Hodgkin3202413760.340 Why?
Quality of Life82024134620.290 Why?
Telemedicine1202431050.280 Why?
Neoplasms32024223400.260 Why?
Hematopoietic Stem Cell Transplantation3202157530.250 Why?
Physician-Patient Relations1201732780.220 Why?
Immunotherapy, Adoptive3202415100.200 Why?
Lung Neoplasms12024134510.170 Why?
Adaptation, Psychological3202426600.150 Why?
Anxiety5202446710.140 Why?
Lymphocyte Depletion120196050.140 Why?
Leukemia, Myeloid, Acute2202236460.130 Why?
Empathy120214740.130 Why?
Perception1202212050.130 Why?
Antigens, CD19120194430.130 Why?
International Classification of Diseases120219350.120 Why?
Neurotoxicity Syndromes120193020.120 Why?
Prognosis52024299220.120 Why?
Patient Acceptance of Health Care2202432300.110 Why?
Depression4202482370.090 Why?
Social Support1202121920.090 Why?
Receptors, Antigen, T-Cell1201925700.080 Why?
Communication1202439160.080 Why?
Palliative Care1202436450.080 Why?
Graft vs Host Disease1202130780.070 Why?
Cross-Sectional Studies32024263180.070 Why?
T-Lymphocytes12024102610.060 Why?
Humans1620247659680.060 Why?
Immunotherapy1201947520.050 Why?
Electronics120213140.040 Why?
Aged, 80 and over12024594890.040 Why?
Physicians1201745880.040 Why?
Middle Aged520242230090.040 Why?
Retrospective Studies22024815140.040 Why?
Antineoplastic Combined Chemotherapy Protocols12019118680.040 Why?
Vidarabine120193430.040 Why?
Longitudinal Studies22024147510.030 Why?
Death120216860.030 Why?
Male520243636980.030 Why?
Aged220241711170.030 Why?
Checklist120218480.030 Why?
Cyclophosphamide1201922280.030 Why?
Female420243961120.020 Why?
Caregivers1202423070.020 Why?
Regression Analysis1202163220.020 Why?
Pilot Projects1202487330.020 Why?
Disease Management1201925350.020 Why?
Massachusetts1202188750.020 Why?
Socioeconomic Factors1202178380.020 Why?
Combined Modality Therapy1201985290.020 Why?
Clinical Trials as Topic1202280410.020 Why?
Databases, Factual1202180670.020 Why?
Adult320242230440.010 Why?
Neoplasm Recurrence, Local1202393730.010 Why?
Survival Rate12019127950.010 Why?
Delivery of Health Care1202153700.010 Why?
Stress Disorders, Post-Traumatic1202146280.010 Why?
Algorithms12021140710.010 Why?
Follow-Up Studies12019391930.010 Why?
Adolescent12024888350.010 Why?
Treatment Outcome12021651880.010 Why?
Animals120191687640.000 Why?
Dhawale's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (66)
Explore
_
Co-Authors (20)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
© 2025 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.